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Abstract: The chemical analysis of insect-associated Actinobacteria has attracted the interest of
natural product chemists in the past years as bacterial-produced metabolites are sought to be crucial
for sustaining and protecting the insect host. The objective of our study was to evaluate the phylogeny
and bioprospecting of Actinobacteria associated with fungus-growing termites. We characterized 97
Actinobacteria from the gut, exoskeleton, and fungus garden (comb) of the fungus-growing termite
Macrotermes natalensis and used two different bioassays to assess their general antimicrobial activity.
We selected two strains for chemical analysis and investigated the culture broth of the axenic strains
and fungus-actinobacterium co-cultures. From these studies, we identified the previously-reported
PKS-derived barceloneic acid A and the PKS-derived rubterolones. Analysis of culture broth yielded
a new dichlorinated diketopiperazine derivative and two new tetracyclic lanthipeptides, named
rubrominins A and B. The discussed natural products highlight that insect-associated Actinobacteria
are highly prolific natural product producers yielding important chemical scaffolds urgently needed
for future drug development programs.
Keywords: actinobacteria; symbiosis; secondary metabolites; drug discovery; chemical ecology
1. Introduction
Historically, natural products of microbial origin have been a rich source of drug-like lead
structures and until today, almost 35% of all drugs are based on structures of naturally occurring small
molecules [1–3]. Despite this prevalence, natural product chemistry has faced declining enthusiasm
and dwindling investments for decades as bioactivity-guided screening programs resulted mostly
in the rediscovery of already known compounds. The low success rates of industrial antibiotic drug
discovery programs worldwide resulted in todays’ eminent lack of new antibiotic drug leads. At the
same time, increasing numbers of multiresistant human-pathogenic microbes causing non-treatable
infections in clinics are reported. These eminent health threats led to the recent realization that new
natural product derived scaffolds are urgently needed to combat the life threating infections caused by
multidrug resistant pathogens.
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The revolutionary developments in genome sequencing and analytical technologies in the
last decade have dramatically changed the field of natural product discovery [4]. Particularly,
ecology-driven natural product discovery approaches including the chemical analyses of symbiotic
microorganisms, in combination with omics-based dereplication strategies, have become highly
efficient approaches to identify new natural products with unique chemical scaffolds and
bioactivities [5–8]. Most notably, the analysis of insect-microbe symbioses, and more specifically
insect-Actinobacteria interactions, have been the focus of a series of recent natural product discovery
studies, as bacterial symbionts are required to communicate with the host or participate in host defense
using small molecules. The importance of defensive secondary metabolites in insect-Actinobacteria
symbiosis is evident, as exemplified in firebugs (Pyrrhocoridae: Pyrrhocoris apterus) [9] or the European
beewolf (Crabronidae: Philanthus) that harbors antibiotic-producing Streptomyces in their antennae
to help protect wasp larvae from fungal infections [10]. Similarly, fungus-growing ants (Attini
species) carry symbiotic Pseudonocardia that help protect the ants’ fungal gardens against specialized
parasites [11–13]. Insect-associated Actinobacteria have also been reported from other insects, including
Ambrosia beetles [14], dung beetles (Scarabaeidae: Copris tripartitus) [15,16], and fungus-growing
termites [17,18].
We have recently focused efforts on the chemical analyses of the delicate interplay between
fungus-growing termites (Termitidae: Macrotermitinae), their fungal mutualist Termitomyces
(Basidiomycota: Agaricales: Lyophyllaceae), and bacteria residing within termite guts and fungus
gardens (fungus combs). Fungus-growing termites cultivate the fungal mutualist in subterranean
monoculture fungus gardens as their main food source [19]. The maintenance of such a monoculture
in a nutritionally-rich environment is expected to make the fungal garden prone to exploitation by
competitors and disease, such as mites, nematodes, and co-occurring fungi. In addition to antimicrobial
and behavioral defense mechanisms of the termites themselves [20], it has been hypothesized that
bacteria are employed as defensive symbionts [17,21].
Using bacteria-fungus interaction assays, we have demonstrated that Actinobacteria associated
with Macrotermes natalensis secrete secondary metabolite mixtures that are active against co-occurring
fungi and the weed fungus Pseudoxylaria sp. (Ascomycota: Xylariales: Xylariaceae) [22]. Subsequent
analysis of single species resulted in the isolation of a new geldanamycin derivative, named
natalamycin (4), from Streptomyces sp. M56 (Figure 1) [23]. In a follow-up study, activity-based analysis
of Amycolatopsis sp. M39 identified several new macrolactams named macrotermycins (macrotermycin
A, 5) [24], and comparative genome and metabolomic analysis of Streptomyces sp. M41 yielded,
amongst others, the novel depsipeptide dentigerumycin B (2) [25]. Recently, activity and NMR-guided
analysis of Streptomyces sp. RB1 led to the isolation of termisoflavones A–C (termisoflavone A, 1) [26],
and co-cultivation studies of Actinomadura sp. RB29 yielded a new group of tropolone derivatives
named rubterolones (e.g., rubterolone D, 6) [27].
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Figure 1. Phylogenetic placement Actinobacteria that have previously been reported from fungus-
growing termites and isolated natural products: termisoflavone A (1) from Streptomyces sp. RB1, 
dentigerumycin B (2) from Streptomyces sp. M41, actinomycin D (3) from Streptomyces sp. RB94, 
natalamycin A (4) from Streptomyces sp. M56, macrotermycin A (5) from Amycolatopsis sp. M39, and 
rubterolone D (6) from Actinomadura sp. RB29. 
Here, we present a comprehensive phylogenetic and bioactivity survey of Actinobacteria 
associated with the fungus-growing termite M. natalensis. In summary, our study shows that 
bioprospecting for secondary metabolites in Actinobacteria associated with this termite species leads 
to the identification of novel natural with unique chemical scaffolds and provides a foundation for 
gaining a better understanding of the general sanitary role of Actinobacteria in fungus-growing 
termites. 
2. Results 
2.1. Phylogenetic Diversity 
To assess the culturable actinobacterial diversity, we chose three different sample origins (fresh 
fungus comb material and the termite worker exoskeleton and gut content) from eleven different M. 
natalensis termite colonies collected in South Africa (Table S1). We focused on the isolation of 
Actinobacteria capable of living on cellulose or chitin as a sole C-source (Figure 2), as these bacterial 
isolates are likely adapted to living within the cellulose-rich comb material [28]. Actinobacteria (97) 
with unique morphotypes were isolated from the termite gut (68), termite abdomen (13), and fungus 
comb material (16) (Table 1, Table S2). Subsequent phylogenetic analysis of all isolates using 16S 
rRNA sequencing was conducted, showing that the characterized isolates did not form a 
monophyletic group (Figure 3, Figure S1) but were interspersed within the Actinobacterium phylum 
[17,29]. Interestingly, 73 isolates belonged to the genus Streptomyces and covered most of the reported 
phylogenetic diversity of this widespread genus. The remaining 24 isolates belonged to 12 genera 
Figure 1. Phylogenetic placement Actinobacteria that have previously been reported from fungus-
growing termites and isolated natural products: termisoflavone A (1) from Streptomyces sp. RB1,
dentigerumycin B (2) from Streptomyces sp. M41, actinomycin D (3) from Streptomyces sp. RB94,
natalamycin A (4) from Streptomyces sp. M56, macrotermycin A (5) from Amycolatopsis sp. M39,
and rubterolone D (6) from Actinomadura sp. RB29.
Here, we present a comprehensive phylogenetic and bioactivity survey of Actinobacteria
associated with the fungus-growing termite M. natalensis. In summary, our study shows that
bioprospecting for secondary metabolites in Actinobacteria associated with this termite species leads to
the identification of novel natural with unique chemical scaffolds and provides a foundation for gaining
a better understanding of the general sanitary role of Actinobacteria in fungus-growing termites.
2. Results
2.1. Phylogenetic Diversity
To assess the culturable actinobacterial diversity, we chose three different sample origins (fresh
fungus comb material and the termite worker exoskeleton and gut content) from eleven different
M. natalensis termite colonies collected in South Africa (Table S1). We focused on the isolation of
Actinobacteria capable of living on cellulose or chitin as a sole C-source (Figure 2), as these bacterial
isolates are likely adapted to living within the cellulose-rich comb material [28]. Actinobacteria (97)
with unique morphotypes were isolated from the termite gut (68), termite abdomen (13), and fungus
comb material (16) (Table 1, Table S2). Subsequent phylogenetic analysis of all isolates using 16S rRNA
sequencing was conducted, showing that the characterized isolates did not form a monophyletic group
(Figure 3, Figure S1) but were interspersed within the Actinobacterium phylum [17,29]. Interestingly,
73 isolates belonged to the genus Streptomyces and covered most of the reported phylogenetic diversity
of this widespread genus. The remaining 24 isolates belonged to 12 genera within the Actinobacteria
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(Table 1). For species delineation a threshold of <98.65% sequence similarity was applied revealing
seven putative new Actinobacteria species (Figure 4, Table S3) [30,31].
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Figure 2. (A) Royal chamber of Macrotermes natalensis containing the queen, the king, and workers. 
(B) Fungus comb with a major and a minor soldier. (C) A plate exemplifying the diversity of 
culturable bacteria that can be isolated from the gut of a fungus-growing termite worker. 
Table 1. The number of Actinobacteria isolated within this study and by Visser et al. [17], and their 
origin of isolation by genera and family. 
Genus Family 
This Study:  
Origin of Isolation  
(Number of Isolates) 
Visser et al. [17]  
Origin of Isolation  
(Number of Isolates) 
Termite 
Gut 
Termite 
Exoskeleton 
Fungus 
Comb 
Termite 
Exoskeleton 
Fungus 
Comb 
Streptomyces Streptomycetaceae 46 14 13 13 2 
Kitasatospora Streptomycetaceae 0 0 0 2 0 
Actinomadura Thermomonosporaceae 4 1 0 1 0 
Leifsonia Microbacteriaceae 3 0 0 0 0 
Curtobacterium Microbacteriaceae 1 0 0 0 0 
Arthrobacter Micrococcaceae 0 1 0 0 0 
Micromonospora Micromonosporaceae 3 0 0 1 1 
Nocardia Nocardiaceae 3 0 0 0 0 
Aeromicrobium Nocardioidaceae 1 0 0 0 0 
Cellulosimicrobium Promicromonosporaceae 1 0 0 0 0 
Mycobacterium Mycobacteriaceae 3 0 0 0 0 
Sphaerisporangium Streptosporangiaceae 1 0 0 0 0 
Microbispora Streptosporangiaceae 1 0 0 0 0 
Luteimicrobium 
family of order 
Micrococcales 
1 0 0 0 0 
Figure 2. (A) Royal chamber of Macrotermes natalensis containing the queen, the king, and workers. (B)
Fungus comb with a major and a minor soldier. (C) A plate exemplifying the diversity of culturable
bacteria that can be isolated from the gut of a fungus-growing termite worker.
Table 1. The nu ber of Actinobacteria isolated ithin this study and by Visser et al. [17], and their
origin of isolation by genera and family.
Genus Family
This Study:
Origin of Isolation
(Number of Isolates)
Vi ser et al. [17]
rigin of Isolation
( umber of Isolates)
Termite
Gut
Termite
Exoskeleton
Fungus
Comb
Termite
Exoskeleton
Fungus
Comb
Streptomyces Streptomyceta ae 46 14 13 13 2
Kitasatospora Strepto ycetaceae 0 0 0 2 0
Actinomadura Thermomonosporaceae 4 1 0 1 0
Leifsonia Microbacteriaceae 3 0 0 0 0
Curtobacterium Microba teriacea 1 0 0 0 0
Arth bacter Micrococcaceae 0 1 0 0 0
Micromonospora Micromonosporaceae 3 0 0 1 1
Nocardia Nocardiaceae 3 0 0 0 0
Aeromicrobium Nocardi idaceae 1 0 0 0 0
Cellulosimi robium Promicromonospor ceae 1 0 0 0 0
Mycobacterium Mycobacteriaceae 3 0 0 0 0
Sphaerisporangium Streptosporangiacea 1 0 0 0 0
Microbispora Streptosporangiaceae 1 0 0 0 0
Luteimicrobium family of orderMicrococcales 1 0 0 0 0
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Figure 3. Phylogeny and antimicrobial activity of newly isolated Actinobacteria: (A) Phylogenetic 
analysis based on near full-length 16S rRNA sequences of isolated Actinobacteria including 
phylogenetic placement to the family level. An unrooted neighbor-joining distance tree is shown with 
branch values indicating bootstrap support (>50 are given) of 1000 pseudoreplicates, tree was 
constructed with Mega 7.0 and edited with iTOL v3. Middle: Origin of isolation: termite abdomen: 
black box, termite gut: brown circle, fungus comb: green star. Right: activity heatmap against test 
strains Bacillus subtilis ATCC 6633 (1), Staphylococcus aureus IMET 10760 (2), Escherichia coli SG 458 (3), 
Pseudomonas aeruginosa K799/61 (4), Mycobacterium vaccae IMET 10670 (5), Sporobolomyces salmonicolor 
SBUG 549 (6), Candida albicans BMSY 212 (7) and Penicillium notatum JP36 (8). Representative picture 
of (B) fungus comb, (C) major worker, (D) dissected gut of major worker. 
Figure 3. Phylogeny and antimicrobial activity of newly isolated Actinobacteria: (A) Phylogenetic
analysis based on near full-length 16S rRNA sequences of isolated Actinobacteria including
phylogenetic placement to the family level. An unrooted neighbor-joining distance tree is shown
with branch values indicating bootstrap support (>50 are given) of 1000 pseudoreplicates, tree was
constructed with ega 7.0 and edited with iTOL v3. iddle: Origin of isolation: termite abdomen:
black box, ter ite gut: bro n circle, fungus co b: green star. Right: activity heatmap against test
strains Bacillus subtilis ATCC 6633 (1), Staphylococcus aureus I ET 10760 (2), Escherichia coli SG 458 (3),
Pseudo onas aeruginosa 799/61 (4), Mycobacterium vaccae IMET 10670 (5), Sporobolomyces salmonicolor
SB 549 (6), andida albicans B S 212 (7) and Penicillium notatum JP36 (8). Representative picture of
(B) fungus comb, (C) major worker, (D) dissected gut of major worker.
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Figure 4. Rooted neighbor-joining tree based on near-complete 16S rRNA gene sequences showing 
relationship between putative new Actinobacteria strains (based on 98.65% similarity threshold) and 
closest relatives. Stars (*) indicate branches that were also recovered in maximum-likelihood tree. 
Only bootstrap values above 50% (based on 1000 pseudoreplicates) are shown. Rubrobacter 
xylanophilus was used as an outgroup. The scale bar indicates 0.02 substitutions per nucleotide 
position. 
2.2. Antimicrobial Activities Against Test Strains 
We first assessed the bioactivities of standardized culture extracts (1 mg/mL) of all 97 isolates 
against a panel of test strains, including human-pathogens (the Gram-positive bacterium 
Staphylococcus aureus, the Gram-negative bacterium Pseudomonas aeruginosa, and the fungus Candida 
albicans) (Figure 3, Table S5). While most Streptomyces strains produced compounds with antibacterial 
and antifungal properties, we observed varying intensities of activity. On average, Streptomyces 
extracts (73) inhibited four test strains, but individual strains varied substantially in the number of 
test strains they suppressed. Several Streptomyces extracts showed only antibacterial activity (e.g., 
Streptomyces sp. RB74, Streptomyces sp. RB106 and Streptomyces sp. RB113), while others exhibited only 
antifungal activity (e.g., Streptomyces sp. RB31). Most notably, Streptomyces sp. RB94 and RB100 
showed strong antibacterial activity. In contrast, 11 out of 73 Streptomyces strains (15%) inhibited none 
of the tested strains. Isolates belonging to the genera Actinomadura, Sphaerisporangium and 
Micromonospora inhibited on average three bacterial test strains and only two strains showed 
antifungal activity (Actinomadura sp. RB66 and Actinomadura sp. RB99). In contrast, extracts obtained 
from isolates belonging to Arthrobacter, Cellulosimicrobium, Aeromicrobium, Luteimicrobium and 
Mycobacterium showed almost no inhibitory activity against any of the investigated test strains. 
Thirty-seven extracts with moderate to strong antifungal activity were subjected to a second 
antifungal assay against ecologically-relevant co-occurring fungi derived from termite nests, four 
different fungal cultivar isolates (two species) and two entomopathogenic fungi (Beauvaria bassiana 
ST 17960 and Metarhizium anisopliae ATCC 24942) [32,33]. As depicted in Figure 5, the majority of 
culture extracts inhibited none of the representative competing or mutualistic fungi. Extracts of four 
strains (Streptomyces sp. RB7, RB72, RB13, and RB31) did, however, inhibit on average ten of the 
ecologically-relevant fungal test strains, including the entomopathogenic fungi and Termitomyces 
(Table S6). Interestingly Streptomyces sp. RB116 and Streptomyces sp. RB31 have the same closest type 
strains (Table S3) in the blast search in NCBI (https://blast.ncbi.nlm.nih.gov/Blast.cgi, last visit 26th 
of July, 2018, 00:58 AM) [34], but show variation in antifungal activity (Figure 5, Table S8).  
Figure 4. Rooted neighbor-joining tree based on near-complete 16S rRNA gene sequences showing
relationship between putative ew Actinobacteria strains (based on 98.65% similarity threshold) and
closest relatives. Stars (*) indicate bran hes tha were also recov red in maximu -likelihood tree. Only
bootstrap valu above 50% (based on 1000 pseudoreplic tes) are shown. Rubrobacter xylanophilus was
used as an outgroup. The scale bar indicates 0.02 substitutions per nu leotide positi n.
2.2. Antimicrobial Activities Against Test Strains
We first assessed the bioactivities of standardized culture extracts (1 mg/mL) of all 97 isolates
against a panel of test strains, including human-pathogens (the Gram-positive bacterium Staphylococcus
aureus, the Gram-negative bacterium Pseudomonas aeruginosa, and the fungus Candida albicans) (Figure 3,
Table S5). While most Streptomyces strains produced compounds with antibacterial and antifungal
properties, we observed varying intensities of activity. On average, Streptomyces extracts (73) inhibited
four test strains, but individual strains varied substantially in the number of test strains they suppressed.
Several Streptomyces extracts showed only antibacterial activity (e.g., Streptomyces sp. RB74, Strepto yces
sp. RB106 and Streptomyces sp. RB113), while others exhibited only antifungal activity (e.g., Streptomyces
sp. RB31). Most notably, Streptomyces sp. RB94 and RB100 sho ed strong antibacterial activity. In
contrast, 11 out of 73 Streptomyces strains (15%) inhibited none of the tested strains. Isolates belonging
to the genera Actinomadura, Sphaerisporangium and Micromonospora inhibited on average three bacterial
test strains and only two strains showed antifungal activity (Actinomadura sp. RB66 and Actinomadura
sp. RB99). In contrast, extracts obtained from isolates belonging to Arthrobacter, Cellulosimicrobium,
Aeromicrobium, Luteimicrobium and Mycobacterium showed almost no inhibitory activity against any
of the investigated test strains. Thirty-seven extracts with moderate to strong antifungal activity
were subjected to a second antifungal assay against ecologically-relevant co-occurring fungi derived
from termite nests, four different fungal cultivar isolates (two species) and two entomopathogenic
fungi (Beauvaria bassiana ST 17960 and Metarhizium anisopliae ATCC 24942) [32,33]. As depicted in
Figure 5, the majority of culture extracts inhibited none of the representative competing or mutualistic
fungi. Extracts of four strains (Streptomyces sp. RB7, RB72, RB13, and RB31) did, however, inhibit on
average ten of the ecologically-relevant fungal test strains, including the entomopathogenic fungi and
Termitomyces (Table S6). Interestingly Streptomyces sp. RB116 and Streptomyces sp. RB31 have the same
closest type strains (Table S3) in the blast search in NCBI (https://blast.ncbi.nlm.nih.gov/Blast.cgi, last
visit 26th of July, 2018, 00:58 AM) [34], but show variation in antifungal activity (Figure 5, Table S8).
Antibiotics 2018, 7, 83 7 of 25
Antibiotics 2018, 7, x 7 of 24 
 
Figure 5. Phylogeny and antifungal activity of isolated Actinobacteria. Left: Phylogenetic analysis 
based on near full-length 16S rRNA sequences of isolated Actinobacteria. An unrooted maximum-
likelihood distance tree is shown with branch values indicating bootstrap support (>50 are given) of 
1000 pseudoreplicates; tree was constructed with Mega 7.0 and edited with iTOL v3. Right: Antifungal 
activity assays of 37 different culture extracts against ecologically relevant fungi: #1: Cladosporium sp., 
#2: Cladosporium sp., #4: Pleosporales sp., #5: Fusarium sp., #8: Coriolopsis sp., #10: Fusarium sp., #12: 
Cunninghamella sp., #13: Cladosporium sp., #15: Alternaria sp., #17: Trichoderma sp., #22: Trichoderma sp., 
#24: Hypocrea sp., T115: Termitomyces sp., T112: Termitomyces sp., T153: Termitomyces sp., P5: 
Termitomyces sp., MA: Metarhizium anisopliae ATCC 24942, and BB: Beauveria bassiana ST 17960. 
2.3. Chemical Analysis 
As gene expression of important biosynthetic clusters often is under the control of promoters 
that respond to certain external factors, cultivation using standard laboratory conditions is likely to 
lead to limited amount of secondary metabolite production. To activate so-called “cryptic” gene 
clusters, it is often necessary to mimic natural key stress factors such as limited nutrient availability 
or the presence of other potentially competing organisms, as exemplified in a recent study of 
Amycolatopsis sp. M39 [24]. We therefore selected Actinomadura sp. RB29 and Streptomyces sp. RB108, 
and subjected both strains to co-cultivation set-ups against co-isolated fungi to stimulate the 
production of cryptic metabolites.  
First, we tested strain RB108, as comparative phenotypical and phylogenetic analyses indicated 
it to be a novel Streptomyces species (Figure S1, Table S3). Although standardized extracts of RB108 
showed only moderate antifungal activity (Figure 3, Table S5), co-cultivation induced a strong 
antifungal activity against almost all tested fungal strains (Table S9) and an increased brownish 
pigment production. Due to the large inhibition zone, we selected co-cultivation set-up 
RB108/Pleosporales sp. #4 for in-depth analysis. We performed comparative ultra-performance-liquid 
Figure 5. Phylogeny and antifungal activity of isolated Actinobacteria. Left: Phylogenetic analysis
based on near full-length 16S rRNA sequences of isolated Actinobacteria. An unrooted
maximum-likelihood distance tree is shown with branch values indicating bootstrap support (>50
are given) of 1000 pseudoreplicates; tree was constructed with Mega 7.0 and edited with iTOL v3.
Right: Antifungal activity assays of 37 different culture extracts against ecologically relevant fungi:
#1: Cladosporium sp., #2: Cladosporium sp., #4: Pleosporales sp., #5: Fusarium sp., #8: Coriolopsis sp., #10:
Fusarium sp., #12: Cunninghamella sp., #13: Cladosporium sp., #15: Alternaria sp., #17: Trichoderma sp., #22:
Trichoderma sp., #24: Hypocrea sp., T115: Termitomyces sp., T112: Termitomyces sp., T153: Termitomyces sp.,
P5: Termitomyces sp., MA: Metarhizium anisopliae ATCC 24942, and BB: Beauveria bassiana ST 17960.
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expres ion of important biosynthetic lusters often is under the control of promoters that
respond to certain external factors, cultivation using sta dard laboratory conditions is likely to lead t
limited a ount of secondary metabolite production. To a tivate s -called “cryptic” gene clusters, it is
often necessary to mimic natural key stress factors such as limited nutrient availability or the presence
f ot er potentially c mpeting organisms, as exemplified in a recent study of Amycolatopsis sp. M39 [24].
We therefore selected Actinomadura sp. RB29 and Streptomyces sp. RB108, and subjected both strains to
co-cultivation set-ups agai st co-isolated fungi to stimul te the pr duction of cryptic metabolit s.
First, we tested strain RB108, as comparative phenotypical and phylogenetic analyses indicated
it to be a novel S reptomyces species (Figure S1, Table S3). Although standardized extracts of RB108
showed only moderate antifungal activity (Figure 3, Table S5), co-cultivation induced a strong
antifungal activity against almost all tested fungal st ains ( l S9) and an increased brownish pigment
prod ction. Due to the large inhibition zone, we selected co-cultivation set-up RB108/Pleosporales p.
Antibiotics 2018, 7, 83 8 of 25
#4 for in-depth analysis. We performed comparative ultra-performance-liquid chromatography-mass
spectrometry (UHPLC-MS, Shimadzu, Japan) analysis of concentrated extracts obtained from the
zone of inhibition (ZOI). In addition to several other upregulated signals of minor intensity, a distinct
UV-detectable metabolite (m/z = 303.1/321.1) was found to be only produced in co-cultivation with
Pleosporales sp. #4. Mass spectrometry (MS)-guided high pressure liquid chromatography (HPLC,
Shimadzu, Japan) purification resulted in the isolation of barceloneic acid A (7) (Figure 6), a fungal
metabolite acting as a farnesyl-protein transferase inhibitor [35]. We then performed Matrix Assisted
Laser Desorption Ionization Imaging MS (MALDI Imaging MS, Bruker Daltonics) to resolve the spatial
distribution of 7 and to identify possible antifungal candidates from RB108. However, due to low
ionization capacity of this compound class, a clear spatial location of barceloneic acid A (7) was
not observable. Instead, the detailed analysis of the co-culture assay revealed a cluster of ions with
m/z values between 2000 Da and 2500 Da (m/z 2188.15 and m/z 2134.71 being the most intense) that
were upregulated and accumulated in the center and on the edges of the colonies facing the fungus
Pleosporales sp. #4 (Figure 7). This m/z range is typical for ribosomally-synthesized peptides (RiPPs)
often associated with high antimicrobial activities. We currently hypothesize that Pleosporales sp. #4
modulates the interaction with strain RB108 using barceloneic acid A (7) and stimulates the production
of RiPPs of yet unknown composition.
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Trichoderma sp. #22; (B) positive control: Trichoderma sp. #22 in the presence of AmpB; (C) co-cultivation
of Actinomadura sp. RB29 (middle) and Trichoderma sp. #22 (edge of the plate); (D) axenic culture of
Actinomadura sp. RB29; (E) Representative UHPLC-MS analysis (535 nm) of zone of inhibition extracts:
EIC (+) of rubterolone A, B, and D at m/z 414.1, 496.1, and 554.1 and structures of isolated rubterolone
A (8), B (9), and D (6); (F) production of banegasine (10) on ISP2 agar plate and extract with 1% AcOH
containing MeOH; and (G) production of cyclo(NMe-L-3,5-dichlorotyrosine-Dhb) (11) in Soya Broth
(here represent from XAD16 80% MeOH eluate).
We also analyzed standard culture extracts using LC-HRMS and detected, in addition to several
of the previously reported rubterolone derivatives, a RiPP-type MS2 pattern of two parent ions
m/z at 957.8 ([M + 2H]2+) and 993.5 ([M + 2H]2+) within the SPE 70% and 80% MeOH C18-SPE
eluates. Purification by Sephadex LH20 resin and semipreparative HPLC purification resulted in the
identification of two tetracyclic lanthipeptides rubrominin A (12) and B (13).
The molecular formulas of 12 and 13 were established to be C80H115N21O28S3 and
C83H120N22O29S3 based on the exact mass analysis of protonated ion 12 (m/z 1914.73938 [M + H]+,
calcd. 1914.7 ∆ = −3.21 ppm) and 13 (m/z 1985.77539 [M + H]+, calcd. 1985.77141 ∆ = 2.01 ppm).
The mass difference of 71.03601 between 12 and 13 suggested an additional alanine residue from the
N-terminus. The MS2 spectra were recorded, submitted to Global Natural Product Social Molecular
Networking (GNPS) and processed by RiPPquest [37]. The combined analysis led to the identification
of a putative candidate peptide ([A]CSSTCTSGPFTFACDGTTKG), which is presumably modified
by dehydrations and oxidation reactions. However, the estimate p-value of PSM (peptide-spectrum
matches) did not allow an assignment of the modified positions.
Genome analysis of Actinomadura sp. RB29 using antiSMASH [38] and Blast resulted in the
identification of a cinnamycin-homolog gene cluster [39,40], which we named rum. It contains 21
open reading frames (ORF) and homolog genes to cinA, cinM, cinX, and cinorf7 from Streptomyces
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cinnamoneous (Figure S6, Table S11). The candidate peptide sequence ([A]CSSTCTSGPFTFACDGTTKG)
is located at the N-terminus of RumA. Furthermore, a precursor peptide sequence and an AYA (AXA
motif) between the C-terminus leader sequence and the core region of RumA was identified; both of
which are likely be recognized by a type I signal peptidases of the general secretory (sec) pathway.
The RumM sequence shows high homology with other class II LanM (lanthipeptide synthetase)
enzymes and is likely to catalyze the dehydration of Thr4, Ser7, Thr11, and Thr18 in the precursor
peptide and the subsequent addition/cyclization reaction of three Cys residues to form the three
methyllanthionine bridges. In addition, RumX, a homolog Nif11 family protein, might hydroxylate
Asp15 of the precursor peptide. The Cinorf7 homolog named RumN is presumably involved in the
formation of the cross-link between Lys19 and dehydroalanine7 to form a lysinoalanine bridge. We
then performed isotope labeling experiments using L-serine-2,3,3-D3 and DL-cysteine-3,3-D2, which
showed the incorporation of both, serine and cysteine, into the core peptide. Subsequent Marfey’s
derivatization of both compounds revealed the partial amino acid composition in the matured peptide
as L-Phe, L-Ala, Gly, L-Ser, L-Thr, and L-Pro. 1H NMR spectra and COSY correlation of 12 and 13
recorded in D2O revealed amino acid-like chemical shifts, and 10% D2O/90% H2O deduced the amide
chemical shifts from peptide bonds, in particular phenylalanine and alanine spin systems. Due to the
dominant rubterolone formation and low production titers of 12 and 13, full NMR assignment and
evaluation of the bioactivities is the topic of current investigations. Based on the acquired genomic data,
MS2-analysis and Marfey analysis, we are confident propose the tetracyclic structure of rubrominins A
(12) and B (13) as depicted in Figure 9.
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3. Discussion
3.1. Phylogenetic and Ecological Relevance of the Actinobacteria
Termites forage for a broad range of organic material to manure the mutualistic food fungus
and this sub trate is expected to contain a broad diversity of f ngal and bacterial isolates. After
predigestion of the harvested material during a first gut passage [20], the termites deposit the resulting
fec s as fresh comb material for fungal growth. However, it is a conundrum that active combs lack
any signs of the presence of fungal contaminates or diseases. This suggests that the gut and comb
environment, including the microbial community, provides effective defenses against any incoming
potentially parasitic a d competitive species. To test the hypothesis that Actinobacteria provide h ve
the potential to be line of defense against invading fungal species, and to identify novel antimicrobial
metabolites produced by these bacteria, we investigated the culturable actinobact rial diversity of guts,
combs, d exoskeletons of the fungus-growing termite species M. natale sis. Here, we acknowledge
the fact that due to the limited numbers of t sted culture conditio s, we miss “unculturable” and
extremophilic members.
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Overall, Actinobacteria were found throughout all samples and colonies of M. natalensis with 97
representatives, covering twelve genera, ten families, and two orders of the known actinobacterial
diversity [29]. We found a dominance of diverse Streptomyces species (75%) and a low abundances
of other genera, such as Actinomadura, Microbispora, Micromonospora, and Nocardia consistent with
previous findings [17,29,41]. Here, it is interesting to note that Actinomadura are frequently isolated
from soil [42] and from other social insects such as bee hives [43], similar to members of the genera
Microbispora, Micromonospora, and Nocardia [44,45].
Based on the threshold of 98.65% sequence similarity of the 16S rRNA gene for species
delimination, we defined seven isolates as putative novel species (Figure 4), and which are currently
investigated for their physiological properties and biosynthetic potential.
The dominant isolation rates of Streptomyces from all biological samples and the lack of
phylogenetic specificity between Actinobacteria genera and the different biological samples
(exoskeleton, gut fluids, and fungus comb), may suggest that Actinobacteria are transient microbes.
They are presumably taken up as spores or vegetative mycelium present within digested soil particles
and then incorporated as part of the fecal deposits within the comb material; a similar strategy allows
the introduction and propagation of the fungal mutualist Termitomyces.
In particular, the high isolation rate of Actinobacteria from anaerobic gut fluids was intriguing as
previous metagenomic studies indicate that the microbial gut community is dominated by members of
Firmicutes, Bacteroidetes, Spirochaetes, Proteobacteria, and Synergistetes, with the most abundant
genera being anaerobic or microaerophilic, such as Alistipes, Treponema, Desulfovibrio, Paludibacter, and
a member of the Synergistaceae [45]. 16S rRNA sequences affiliated with Actinobacteria appear to
account for only a minor component of the gut bacterial microbiota. Similar results were obtained in a
related study of the fungus-growing termite Odontotermes formosanus, with four phylogenetic groups,
Firmicutes, the Bacteroidetes/Chlorobi group, Proteobacteria, and Actinobacteria dominating [46].
Considering the anaerobic or microaerophilic environment of the gut compartments, it is likely that
only a small fraction of Actinobacteria are actively growing (Table S10) [47,48], and most of our isolates
might originate from germination of spores present within the gut fluids [49].
In contrast to gut microbial communities, taxonomic analyses of the comb microbiota of different
termite genera showed a clear shift in microbial composition to a more dynamic microbiota of about
33 different phyla, with Firmicutes, Bacteroidetes, Proteobacteria, and Actinobacteria (47 families
of four different classes) as the most abundant phyla [50]. It has been hypothesized that this shift
would allow for a second microbe-assisted aerobic decomposition, detoxification of plant substrates,
and defense against invading and potentially non-beneficial microbes. In particular, Actinobacteria
have a multitude of enzymatic capabilities to break down polysaccharides (cellulose, chitin, xylan,
and agar) [29,41,51], and to detoxify microbial metabolites, metabolic capacities that most likely
contribute to the optimal growth conditions for Termitomyces.
3.2. Bioactivities and Natural Products
Using two standardized bioassays, we explored the antimicrobial activities of associated
Actinobacteria. More than three quarters of the actinobacterial isolates produced compounds with
antimicrobial activity against one or more test strains (human-pathogenic), but only four of the
generated extracts revealed antifungal activity against fungal garden weeds, in addition to inhibitory
activity against the fungal cultivar. Here, we acknowledge the possibility that metabolite secretion
of isolated bacterial strains is strongly depended on the culture environment. We also noticed
that even very closely related strains showed a high variability amongst activities. In subsequent
actinobacterium-fungus co-cultivation studies we showed that metabolite production was stimulated
in the presence of a fungal species and that strains which previously secreted no antifungal metabolites
were stimulated and produced compounds with strong antifungal activity. We decided to analyze two
co-culture case studies in detail. In the first case study, we analyzed the interaction zone of a co-culture
between Streptomyces sp. RB108 and Pleosporales sp. #4 using LC-MS and MALDI Imaging to visualize
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the production of potential “cryptic” metabolites. UHPLC-MS-based analysis of the co-culture between
Streptomyces sp. RB108 and Pleosporales sp. #4 revealed that the fungal metabolite barceloneic acid A (7),
a known farnesyl-protein transferase inhibitor, was strongly upregulated. Although barceloneic acid A
did not reveal any antimicrobial activity, it is likely that the molecule modulates the bacterium-fungal
interactions using yet unknown mechanisms. We then used a MALDI imaging approach to identify
the origin of the antifungal activities and found an increased production of RiPP-like metabolites,
which are known for antimicrobial activities and their detailed structural analysis is topic of recent
investigations. Upregulations of RiPP-like metabolites having different m/z ranges were also observed
in other co-cultivation studies; revealing a glimpse into the plethora of metabolites present within
complex multipartner interactions.
In a second case study, we analyzed the metabolome of Actinomadura sp. RB 29 in more detail,
as growth studies on different media and co-culture assay induced strong metabolomic shifts and
inducible antifungal activity. Comparative analysis revealed that in addition to the previously
reported rubterolones, the natural product banegasine (10) and dichlorinated diketopiperazine
derivative 11 were produced. Banegasine (10) displayed moderate antimicrobial activities against
Gram-positive bacteria, including Mycobacteria, and is known to potentiate the antimicrobial activity
of, for example, pyrrolnitrin [52]. Although the dichlorinated diketopiperazine derivative 11 has
been previously reported as part of a screening library, its origin has been undisclosed [36]. In
general, diketopiperazine derivatives are common secondary metabolites from bacteria and fungi
and the combination of natural and modified amino acids produces diverse structural and bioactivity
diversity. The structure of compound 11 is unique as it contains two modified amino acids. First, it
contains a 2,3-dehydro-2-aminobutyric acid (Dhb), which presumably originates from the dehydration
of threonine [53], and is frequently found in bioactive natural products family like nonribosomal
peptides [54] and lanthipeptides [55]. Secondly, it contains a 3,5-dichlorotyrosine moiety, which
is a building block of several natural products like chloropeptin [56] from Streptomyces lavendulae,
and cyclo(13,15-dichloro-L-Pro-L-Tyr) from fungi Leptoxyphium sp. In addition, the modified amino
acid has been detected in cuticles from several insect species, where they might play important roles in
the sclerotization process [57]. A similar diketopiperazine cyclo(L-N-MePhe-Dhb) was identified from
Streptomyces globisporus, exhibiting interesting morphogenic and biosynthetic regulator effects [58].
Additionally, we also identified two ribosomally synthesized and post-translationally modified
peptides, named rubrominins A (12) and B (13). The post-translational modification reactions include
the dehydration of Ser residue to dehydroalanine and a cyclization step that includes the addition of
Cys residues to the dehydrated Ser residues yielding the lanthionine and thioether cross-link. The
resulting polycyclic peptides, named lanthipeptides, have constrained conformations that often confer
their biological activities. Due to the very low production titers of rubrominins A (12) and B (13) in
co-cultures and axenic cultures, their biological activities have not yet been elucidated and is a topic of
current investigations.
Overall, the chemical analysis of Actinomadura sp. RB 29 revealed growth-condition dependent
metabolite production, and although the origin of the antifungal activity within co-cultures remains
to be fully elucidated, the identified natural products (rubterolones, banegasine a chlorinated
diketopiperazine derivative 11, and two lanthipeptides 12 and 13) exhibit interesting chemical features
that are key in many pharmacologically important compound classes.
4. Materials and Methods
General procedures: NMR measurements were performed on a Bruker AVANCE III 500 MHz
and 600 MHz spectrometer, equipped with a Bruker Cryoplatform. The chemical shifts are reported
in parts per million (ppm) relative to the solvent residual peak of DMSO-d6 (1H: 2.50 ppm, quintet;
13C: 39.52 ppm, heptet). LC-ESI-HRMS measurements were carried out on an Accela UPLC system
(Thermo Scientific) coupled with an Accucore C18 column (100 mm × 2.1 mm, particle size 2.6 µm)
combined with a Q-Exactive mass spectrometer (Thermo Scientific) equipped with an electrospray ion
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(ESI) source. UHPLC-MS measurements were performed on a Shimadzu LCMS-2020 system equipped
with single quadrupole mass spectrometer using a Phenomenex Kinetex C18 column (50 mm× 2.1 mm,
particle size 1.7 µm, pore diameter 100 Å). The column oven was set to 40 ◦C; scan range of MS was set
to m/z 150–2000 with a scan speed of 10,000 u/s and event time of 0.25 s under positive and negative
mode. The DL temperature was set to 250 ◦C with an interface temperature of 350 ◦C and a heat block
temperature of 400 ◦C. The nebulizing gas flow was set to 1.5 L/min and dry gas flow to 15 L/min.
Semipreparative HPLC was performed on a Shimadzu HPLC system using a Phenomenex Luna C18(2)
250 mm × 10 mm column (particle size 5 µm, pore diameter 100 Å). IR spectra were recorded on
an FT/IR-4100 ATR spectrometer (JASCO). Optical rotations were recorded in methanol on a P-1020
polarimeter (JASCO). Solid phase extraction was carried out using Chromabond C18ec cartridges
filled with 2 g and 10 g of octadecyl-modified silica gel (Macherey-Nagel, Düren, Germany). Open
column chromatography was performed on Sephadex LH20 (GE Healthcare, Hamburg, Deutschland).
Chemicals: Methanol and acetonitrile LC-MS grade (VWR International GmbH, Dresden); water for
analytical and preparative HPLC (Millipore, Darmstadt, Germany); formic acid (Carl Roth, Karlsruhe,
Germany); acetonitrile (VWR as LC-MS grade); media ingredients (Carl Roth, Karlsruhe, Germany).
Sample collections and isolation procedures: Biological material (soldiers, workers, and fungus
comb) was collected from eleven M. natalensis nests (stored in 50% glycerol) and one M. natalensis
and one Odontotermes sp. nest for transcriptomic analysis (Table S1) (stored in RNAlater@, Sigma
Aldrich, St. Louis, MO, USA). Samples were kept on ice immediately after collection and stored at
−80 ◦C within one day. Frozen termite workers (gut and cuticle) and fresh fungus comb material were
used for the isolation of Actinobacteria and each sample was processed separately. First, termites and
fungus comb samples were individually washed with ddH2O (250 µL) and the wash water collected
separately for subsequent isolation procedure. Then, major termite workers were surface sterilized
with 70% ethanol and washed in sterile Ringer solution (7.5 g/L NaCl, 0.35 g/L KCl, 0.21 g/L CaCl2).
Termites were dissected using sterile, fine tipped forceps and intact guts were immediately removed
and stored in 500 µL PBS on ice until further use (5 guts per sample). Dissected guts were crushed
using a sterile pestle and a series of dilution (up to 10−6 in PBS) was produced. Bacteria from each
sample were isolated by plating 100 µL of each dilution series (10−4–10−6) on two different selective
low-nutrient media: chitin and microcrystalline medium supplemented with 0.05 g/L cycloheximide
(Table 2) [17]. Isolates with Actinobacteria-like morphology were transferred to the nutrient-richer
medium ISP2 and subcultured. A total of 68 isolates were obtained from gut compartment, 16 isolates
from termite cuticle, and 13 isolates from fungus comb (Table S2).
Table 2. Media compositions used for initial isolations and subsequent growth assays and
large-scale cultivation.
Medium (Abbreviation) Content Per L
Potato Dextrose Broth (PDB) 26.5 g potato extract glucose (6.5 g potato extract, 20 g glucose)
Potato Dextrose Agar (PDA) 26.5 g potato extract glucose, 20.0 g agar
ISP2 Broth 4.0 g yeast extract, 10.0 g malt extract, 4.0 g glucose
ISP2 Agar 4.0 g yeast extract, 10.0 g malt extract, 4.0 g glucose, 20.0 g agar
Chitin Agar 4.0 g chitin, 0.7 g K2HPO4, 0.3 g KH2PO4, 0.57 g MgSO4·7H2O,0.01 g FeSO4·7H2O, 0.0018 g ZnSO4·7H2O, 0.0016 g MnCl2·4H2O
Minimal Media
2.0 g Na-acetate, 2.0 g NH4Cl 0.7 g K2HPO4, 0.3 g KH2PO4, 0.57 g
MgSO4·7H2O, 0.01 g FeSO4·7H2O, 0.0018 g ZnSO4·7H2O, 0.0016 g
MnCl2·4H2O
MC Agar 5.0 g microcrystalline cellulose, 20.0 g agar
Soya Broth 20.0 g soya flour, 20.0 g glucose, 5.0 g NaCl, 3.0 g CaCO3, 0.25 mLdesmophen
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DNA extraction, PCR amplification, pairwise sequence similarities and phylogenetic analysis:
Actinobacteria were grown in nutrient-rich ISP2 broth for 5 to 7 days at 30 ◦C (150 rpm). Cells
were harvested, and genomic DNA was extracted using the GenJet Genomic DNA Purification Kit
(Thermo Scientific, Waltham, MA, USA, #K0721) following the manufacturer’s instructions with slight
changes (lysozyme incubation time 40 min, protein kinase K treatment 40 min). DNA was quantified
spectrophotometrically using Nanodrop (Thermo Scientific, Waltham, MA, USA). 16S rRNA gene
was amplified using the primers pair 27F/1492R [17]. The amplification reaction was prepared in
25 µL final volume containing: 7.25 µL dH2O, 5.0 µL HF buffer, 5.0 µL of each primer (2.5 µM), 0.5 µL
dNTPs (10 µM), and 0.25 µL Phusion High Fidelity DNA Polymerase (New England Biolabs). PCR
was performed with the conditions: 98 ◦C for 38 s, followed by 32 cycles of 98 ◦C for 30 s, 52 ◦C for 45 s,
72 ◦C for 1 min 20 s, and a final extension of 72 ◦C for 8 min. PCR products were visualized by agarose
gel electrophoresis. PCR reactions were purified using the PCR Purification Kit (Thermo Scientific,
Waltham, MA, USA, #K0702) and sequenced at GATC (Konstanz).
Sequences were checked for purity and mismatches using BioEdit [59]. Forward and reverse
sequences of each sequence were assembled with BioEdit and tested for chimeras using DECIPHER [60].
For strains RB9, RB54, RB74, RB85, and RB129 only reverse or forward sequences were generated
(Table S3). Resulting sequences were used for a BLASTn search in GenBank using “refseq_rna”
database [61]. Pairwise sequence similarities were calculated using the method recommended
by Meier-Kolthoff [30] for 16S rRNA gene available via the GGDC web server available at
http://ggdc.dsmz.de/. Sequence similarities were calculated for all strains with first three hits
(Table S3). A phylogenetic analysis was done with the 16S rRNA sequences (GenBank accession
numbers KX344916-KX344918, KY312017-KY312022, KY558669-KY558746, and MH044507-MH044516)
and the first hit from the BLASTn search (Figure S1, Table S3). Sequences were aligned with muscle [62]
and trimmed using MEGA 7.0.26 [63]. Two different phylogenetic trees were reconstructed with
neighbor-joining [64] and maximum likelihood algorithms (Figure S1) [65].
The evolutionary distance model of Kimura or Tamura and Nei was used to generate evolutionary
distance matrices for the maximum likelihood [66,67], and neighbor joining algorithm with deletion
of complete gaps and missing data. For the maximum-likelihood algorithm, a discrete Gamma
distribution was used (+G) and the rate variation model allowed for some sites to be evolutionarily
invariable (+I). For the neighbor-joining algorithm rate variation among sites was modeled with a
gamma distribution. For all constructed trees the confidence values of nodes were evaluated by
bootstrap analysis based on 1000 resamplings [68]. For graphic design, iTOL v3 (https://itol.embl.de/,
31st of July, 2018) was used with the following settings: leaf sorting = none, branch length = ignore,
scaling factors: Hor = 0.3, Vert: = 0.8) [69].
Phylogenetic comparison of strain RB108: Near-complete 16S rRNA sequences (1365 bp, GenBank
accession number KY558675) were used for a search in NCBI database (reference RNA sequences).
The first three hits were Streptomyces pulveraceus NBRC 3855, Streptomyces atratus NRRL B-16927,
and Streptomyces gelaticus NRRL B-2928 with an Ident value of 99%. All three hits were phenotypically
compared using the Wink compendium [70]. Strain RB108 exhibited a different phenotype compared
to the above listed Streptomyces. Therefore, the full-length 16S rRNA sequence (1514 bp, GenBank
accession number MH828334) was extracted of the genome of strain RB108 and used for comparison.
The first three hits of the reference RNA sequence database were Streptomyces fulvissimus DSM 40593,
Streptomyces caviscabies ATCC 51928, and Streptomyces luridiscabiei S63. Virtual DDH estimation of
strain RB108 and Streptomyces fulvissimus DSM 40593 was performed, resulting in a value of 26.20%
(23.8–28.7%). According to the DDH threshold of <70% both strains can be regarded as distinct two
separate strains [30,31].
Culture extracts: Actinobacteria were cultivated in 25 mL ISP2 or PDB for 4 days at 30 ◦C at
150 rpm, after 4 days additional 25 mL ISP2 or PDB broth were added and cultivation was continued
for another 3 to 5 days. Cultures were centrifuged (6000 rcf, 10 min) and the resulting cell pellets
were lysed using MeOH (9 mL). The resulting methanolic cell extracts were combined with the
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culture supernatant to yield a 20% MeOH culture supernatant. Metabolites from the supernatant were
concentrated using an activated (20% MeOH) Chromabond C18ec cartridges filled with 500 mg of
octadecyl-modified silica gel (Macherey-Nagel, Düren, Germany). (Unless stated otherwise: %MeOH
refers to a mixture of MeOH and dH2O). Metabolites were eluted using 100% MeOH (5 mL) and 100%
acetone (2 mL) and pooled and concentrated in vacuo. The resulting extracts (E) were adjusted with
MeOH to 1 mg/mL and used for bioactivity assays.
Antimicrobial activities against test strains: Antimicrobial assays against Bacillus subtilis ATCC
6633, Staphylococcus aureus IMET 10760, Escherichia coli SG 458, Pseudomonas aeruginosa K799/61,
Mycobacterium vaccae IMET 10670, Sporobolomyces salmonicolor SBUG 549, Candida albicans BMSY 212,
and Penicillium notatum JP36 were done using the broth dilution method according to the NCCLS
(National Committee for Clinical Laboratory Standards) (Table S5).
Antifungal activity assay against co-isolated fungi: All fungal isolates (Table S4) were cultivated
on PDA plates for a maximum of six weeks (23 ◦C) and subcultured by plating mycelium-containing
agar pieces (1 cm × 1 cm) onto fresh PDA. To evaluate antifungal activity, a filter paper disk (d = 6 mm)
was soaked with 10 µL extract (1 mg/mL) and dried (sterile air flow). Depending on the growth
behavior of each fungus, two different assays were applied. Method A (fast-growing fungi), mycelium
covered agar pieces were placed in the middle of a PDA plate (standard petri dish 92 mm × 16 mm)
and sterile filter paper discs were placed at a distance of 1–2 cm from each agar plug. Method B (slow
to medium-fast growing fungi): Fungi were grown in 25 mL PDB for 10 to 14 days at 30 ◦C (150 rpm)
and 500 µL of actively growing culture or a spore solution (M. anisopliae) was used to inoculate a
PDA plate (standard petri dish 92 mm × 16 mm). Distribution of mycelium or spores on plates was
performed using sterile glass beads. Plates were dried and filter discs soaked with equal amounts
(10 µL) of extracts were put onto the PDA plate. Plates were checked daily and the diameter of the
zone of inhibition (ZOI) (no growth, mycelium free) was recorded as a measure of inhibition (Tables S6
and S8). Amphotericin B (8 mg/mL in DMSO) and cycloheximide (50 mg/mL in MeOH) were used
as positive controls, 100% MeOH was used as a negative control. All combinations were prepared
in duplicate.
Co-cultivation studies: Streptomyces sp. RB108 was grown for 14 days at 30 ◦C in ISP2, 25 µL of
liquid culture were used to inoculate ISP2 and PDA plates centrally. Plates were incubated for 7 days
at 30 ◦C until a clear colony (1 cm in diameter) was apparent. Then, plates were inoculated at the edge
of the agar plate with two agar pieces covered with fungal mycelium (Table S9). All combinations were
prepared in triplicate. Amphotericin B (8 mg/mL in MeOH) was used as positive control; ddH2O was
used as negative control. Plates were incubated for 10 days at room temperature Plates were checked
daily for the formation of a zone of inhibition (ZOI). When a clear, stable ZOI was detectable (normally
after 10 days), the ZOI was cut out and extracted with 100% methanol (overnight). Methanol extracts
were dried and stored at−20 ◦C until further use and then subjected to comparative LC-MS and HPLC
analysis. Due to significant upregulation of metabolites during co-cultivation, the combination of
Streptomyces sp. RB108 and fungus #4 was selected for subsequent experiments.
Isolation and structural elucidation of barceloneic acid A (7): For isolation of upregulated
metabolites, large scale co-cultivation of Streptomyces sp. RB108 and Pleosporales sp. #4 was
accomplished by inoculation of 30 PDA agar plates (92 mm × 16 mm, 20 mL agar/plate) as described
above. Each ZOI was excised from the plate then pooled and extracted with MeOH overnight and
solvent removed by evaporation. The resulting crude extract (adjusted to 10% MeOH) was loaded on
an activated and equilibrated SPE C18 column and fractionated by step-gradient from 10% MeOH
to 100% MeOH (100 mL each). The 50% MeOH eluate was separated by semipreparative HPLC to
yield pure compound 7 (m/z 319.19 [M − H]−; 302.95 [M + H − H2O]+). The molecular formula
of barceloneic acid A (7) was assigned as C16H16O7 based on ESI-HRMS (m/z 321.0964 [M + H]+,
calcd. 321.0969 ∆ = −1.46 ppm) (Figure S11). The 1H NMR analysis (Table S12) revealed 13 protons
as sharp signals, suggesting additional three invisible exchangeable protons. Two meta-substituted
aromatic moieties could be deduced according to the 1H chemical shifts and multiplicity of protons
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at δH 6.23 ppm (1H, doublet, J = 2.7 Hz, H-11) and δH 6.44 ppm (1H, doublet, J = 2.7 Hz, H-13); δH
5.95 ppm (1H, broad singlet, H-4) and δH 6.24 ppm (1H, broad singlet, H-6), respectively. The methyl
group at δH3-8 2.07 ppm/δC-8 21.2 ppm was deduced to attach on aromatic ring based on the HMBC
correlations of H3-8 to C-4/C-5/C-6 and H-4 to C-1/C-3/C-5/C-6/C-8 and H-6 to C-1/C-4/C-7/C-8.
The oxygenated methyl moiety at δH3-16 3.68 ppm/δC-16 54.9 ppm was suggested to connect on second
aromatic ring based on the HMBC correlation of H3-16 to C-12. The oxygenated methylene moiety at
δH-15 4.51 ppm (2H, doublet, J = 1.2 Hz, H-15)/δC-15 58.3 ppm was deduced to connect on the same
aromatic ring based on the HMBC correlations of H2-15 to C-9/C-13/C-14, H-13 to C-12/C-14/C-15,
and H-11 to C-9/C-10/C-12/C-13. Finally, the proposed structure of barceloneic acid A (7) matched the
literature reported HRMS and 2D NMR data (Table S13) [35]. NMR spectra are shown in Figure S7–S10.
MS Imaging: An indium tin oxide (ITO) coated glass slide was used for Imaging MS (Bruker
Daltonics, Billerica, MA, USA) and covered with 1 mL of ISP2 and PDA medium, respectively. The
dried agar glass slide was then inoculated with 10 µL of a Streptomyces sp. RB108 liquid culture (middle
of the cover slide) and incubated for 7 d at 30 ◦C. Two square agar pieces (0.3 cm × 0.3 cm) covered
with mycelium of fungus # 4 were arranged at a distance of 1cm on the cover slide (Figure S2). After
an incubation period of 7 days at RT, the slides were dried for an additional half hour next to an open
flame and then sprayed with a saturated solution (7 g/L) of universal MALDI matrix (1:1 mixture of
2,5-dihydroxybenzoic acid and α-cyano-4-hydroxy-cinnamic acid; Sigma Aldrich) in acetonitrile HPLC
grade, using the automatic system ImagePrep device 2.0 (Bruker Daltonics, Bremen, Germany). The
sample was analyzed in an UltrafleXtreme MALDI TOF/TOF (Bruker Daltonics, Bremen, Germany),
which was operated in positive reflector mode using flexControl 3.0 (Bruker, Bremen, Germany). The
analysis was performed in the 100–3000 and 400–4000 Da ranges, with 40% laser intensity (laser type 3),
accumulating 1000 shots by taking 50 random shots at every raster position. Raster width was set
at 150 µm. Spectra were processed with baseline subtraction in flexAnalysis 3.3 (Bruker, Bremen,
Germany). Processed spectra were uploaded in flexImaging 3.0 for visualization and SCILS Lab 2015b
for analysis and representation. Chemical images were obtained after peak alignment on the dataset
using Median normalization and weak denoising.
Isolation and structure elucidation of banegasine (10): Large-scale cultivation of Actinomadura sp.
RB29 was performed by inoculation of 100 ISP2 agar plates (standard 150 mm × 20 mm, 40 mL ISP2
agar/plate) at 30 ◦C for 10 days. Whole agar plates were cut into pieces and extracted twice with 2 L
MeOH (1% AcOH) at 4 ◦C overnight. MeOH/AcOH extracts were filtered and concentrated under
reduced pressure. The crude extract was dissolved using 10% MeOH and loaded on an activated and
equilibrated SPE C18 column (10 g) and fractionated by step-gradient from 10% MeOH to 100% MeOH
(100 mL each). The eluent using 30% MeOH was first purified by Sephadex LH20 using 50% MeOH to
obtain subfractions Fr.3.1–Fr.3.6 (20 mL/Fr.). Concentrated violet band Fr.3.6 was further separated
by semipreparative HPLC to yield pure banegasine (10, 2.0 mg, tR = 6.74 min) using the following
gradient: 0–5 min, 50% B; 5–20 min, 50–100% B; 20–25 min, 100% B (A: dd H2O + 0.1% formic acid; B:
MeOH) with a flow rate of 2.0 mL/min. The molecular formula of banegasine (10) was assigned as
C11H12O2N2 based on ESI-HRMS (m/z 205.0972 [M + H]+, calcd. 205.0972 ∆ = 0.13 ppm) and λmax
217,.278 nm (MeCN/H2O/FA) (Figure S13). The 1H NMR analysis (Table S14) revealed nine protons
as sharp signals, suggesting additional three invisible exchangeable protons. The ortho-substituted
aromatic moiety was deduced from the 1H chemical shifts and multiplicity of protons at δH 7.35 ppm
(1H, doublet, J = 8.1 Hz, H-3′); δH 7.06 ppm (1H, triplet, J = 7.8 Hz, H-4′); δH 6.97 ppm (1H, triplet,
J = 7.2 Hz, H-5′); δH 7.56 ppm (1H, doublet, J = 7.9 Hz, H-6′). The dihydropyrrole moiety was deduced
from the aliphatic protons at δH 3.48 ppm (1H, doublet of doublet, J = 8.6, 3.9 Hz, H-2) and δH 2.99 ppm
(1H, doublet of doublet, J = 15.1, 8.9 Hz, H-3a) and δH 3.31 ppm (1H, doublet of doublet, J = 15.1,
3.7 Hz, H-3b), and olefinic proton at δH 7.22 ppm (1H, doublet, J = 1.2 Hz, H-5). 1H NMR spectrum of
banegasine is shown in Figure S12.
Isolation and structure elucidation of cyclo(NMe-L-3,5-dichlorotyrosine-Dhb) (11): Large-scale
liquid cultivation of Actinomadura sp. RB29 was performed in a 50 L fermenter (20 L Soya Broth
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liquid media, pH 6.8) for 5 days at 28 ◦C (stirring). The culture supernatant was separated from
biomass by separator and collected and loaded onto activated XAD16 resin (1 kg). The resin was
first washed by water (2 L) and then eluted by MeOH/H2O mixture in a step gradient manner, with
1 L 10% MeOH, 30% MeOH, 50% MeOH, 80% MeOH, 100% MeOH, respectively. The corresponding
eluates were concentrated under reduced pressure and redissolved into 50% MeOH or 100% MeOH as
5 mg/mL for standard metabolomic LCMS analysis. The interesting ion with m/z at 328.9 ([M+H]+)
was redetected from 80% MeOH eluate and allowed us to submit this 80% MeOH eluate onto Sephadex
LH20 resin and eluted by 100% MeOH for further purification. Subfractions containing the ion m/z at
328.9 ([M+H]+) were concentrated under reduced pressure and finally purified by semipreparative
HPLC (Nucleodur C18 250 mm × 10 mm) to yield compound 11 (2.0 mg, tR = 13.33 min) using the
following gradient: 0–5 min, 30% B; 5–25 min, 30–83% B; 25–30 min, 100% B (A: dd H2O + 0.1%
formic acid; B: MeCN) with a flow rate of 2.0 mL/min. The molecular formula of compound (11) was
determined as C14H14O3N2Cl2 based on ESI-HRMS analysis (m/z 329.04520 [M + H]+, calcd. 329.04542
∆ = −0.68 ppm) and the isotope abundance of chlorine, and further confirmed by the observation of
14 carbon atoms from 13C-NMR and DEPT135 spectra analysis (Figure S15 and S16). Detailed analysis
of 1D and 2D NMR spectra (Figure S14, S17–S20) indicated two carbonyl groups, one four-substituted
benzyl moiety, one olefinic moiety, one methylene and one methine group, two methyl groups, and one
visible OH/NH signal. The presence of two amide groups (δC-1 165.5 ppm/δC-9 159.0 ppm) suggested
the amino acids origin. Methylated olefin moiety was deduced from the 1H-1H COSY correlation of
H-11 (δH 5.41 ppm/δC 112.0 ppm) to H3-12 (δH 1.46 ppm/δC 10.7 ppm) and the HMBC correlations of
H-11 to C-12, and H3-12 to C-10 and C-11. The further HMBC correlations of H-11 and H3-12 to C-9
(δC 159.0 ppm), OH/NH (δH 9.92 ppm) to C-9 and C-10 suggested the possible dehydroaminobutyric
acid (dhAbu or Dhb) moiety. Second spin system C-2–C-3 from COSY correlation of H-2 to H2-3 and
the aromatic protons (δH-5 6.94 ppm/δC-5 129.7 ppm), and N-methyl group (δH3-8 2.94 ppm/δC3-8
32.1 ppm) were deduced to belong to the substituted tyrosine skeleton based on the deeper observation
of HMBC correlations of H-2 to C-1/-3/-4/-8, and H2-3 to C-1/-2/-4/-5, and H-5 to C-2/-3/-6/-7,
and H3-8 to C-2. Based on the 13C chemical shift compared with the literature [70] and demand of
elemental composition, two chlorine atoms were suggested to attach on the C-6 individually, leading
to the build-up of N-methyl 3,5-dichlorotyrosine moiety. The diketopiperazine structure condensed
from Dhb and N-methyl 3,5-dichlorotyrosine residue was deduced by the HMBC correlations of NH to
C-1/-2, and H-2 to C-9, and H3-8 to C-9. Furthermore this conclusion was confirmed by the observation
of MS fragmentation of m/z 329.04520 ([M+H]+) (Figure S21) and prediction by Mass Frontier 7.0
(Thermo, Figure S22). The fragment ion at m/z 301.05118 (C13H15N2O2Cl2+) might originate from
the diketopiperazine ring opening and loss of carbonyl group; ion at m/z 218.01393 (C9H10NOCl2+)
might derive from the diketopiperazine ring opening and loss of carbonyl group and Dhb moiety;
and ion at m/z 174.97168 (C7H5OCl2+) might represent the (3,5-dichloro-4-hydroxyphenyl)methylium
and the ion at m/z 127.08707 (C6H11N2O+) might deduce from the Dhb moiety and N-methyl group
with rearrangement (e.g., 1-(2-iminobutanoyl)aziridin-1-ium). The NOESY correlation of H3-12 to
NH suggested the configuration of double bond from Dhb moiety as Z form. Finally the planar
structure of 11 was suggested as cyclo(dehydroaminobutyric acid- N-methyl 3,5-dichlorotyrosine).
Comparison of the specific optical rotation of 11 with reported tyrosine or phenylalanine containing
diketopiperazine [71,72], the stereochemistry of N-methyl 3,5-dichlorotyrosine moiety (–104◦) was
deduced to be L-configurated.
cyclo(N-Me-L-3,5-dichlorotyrosine-Dhb) (11): light yellow solid; [α]25D –104.0 (c 0.1 w/v%, MeOH);
UV (MeCN/H2O/FA) λmax 230 nm; IR (ATR) νmax 3857, 3738, 3650, 2925, 2855, 1745, 1683, 1650, 1539,
1512, 1460, 674 cm–1; NMR spectral data, see Table S15; ESI-HRMS [M+H]+ m/z 329.04520 (calcd for
C14H15O3N2Cl2, 329.04542). A SCIFinder search indicated the commercial availability from Aurora
Screening Library (CAS 1798281-02-3) however the natural origin of the compound is unassigned.
Antimicrobial activities of cyclo(N-Me-L-3,5-dichlorotyrosine-Dhb) against test strains:
Antimicrobial assays against Bacillus subtilis ATCC 6633, Staphylococcus aureus IMET 10760, Escherichia
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coli SG 458, Pseudomonas aeruginosa SG137, Pseudomonas aeruginosa K799/61, MRSA Staphylococcus
aureus 134/93, VRSA Enterococcus faecalis 1528, Mycobacterium vaccae IMET 10670, Sporobolomyces
salmonicolor SBUG 549, Candida albicans BMSY 212, and Penicillium notatum JP36 were done using
the broth dilution method according to the NCCLS (National Committee for Clinical Laboratory
Standards) (Table S7).
Isolation and structure elucidation of rubromidin A (12) and B (13): Large-scale liquid cultivation
was performed as mentioned above. SPE 70% and 80% MeOH C18-SPE eluates, which containing ion
with m/z at 957.8 ([M+2H]2+) and 993.5 ([M+2H]2+).
Those two fractions were concentrated under reduced pressure and pooled and resubmitted to
Sephadex LH20 resin and eluted by 100% MeOH for further purification. The subfractions containing
ion with m/z at 957.8 ([M + 2H]2+) and 993.5 ([M + 2H]2+) were concentrated under reduced pressure
and finally purified by semipreparative HPLC (Nucleodur C18 250 mm × 10 mm) to yield rubromidin
A (12, 0.5 mg, tR = 10.02 min) and rubromidin B (13, 0.5 mg, tR = 10.80 min) using the following gradient:
0–20 min, 30% B (A: dd H2O + 0.1% formic acid; B: MeCN) with a flow rate of 2.0 mL/min. ESI-HRMS
analysis of purified lanthipeptide 12 revealed the protonated molecular ion at m/z 1914.73938, as well
as the doubly protonated ion at m/z 957.87408 (Figure S23). The MS2 spectra at m/z 1914.73938 and
957.87408 under positive mode were recorded and submitted to GNPS and processed by RiPPquest,
a tandem mass spectrometry database search tool for identification of microbial RiPPs [73]. The exact
mass of protonated ion of compound 13 was assigned with m/z 1985.77539, by the observation of the
doubly protonated ion at m/z 993.39203 (Figure S24). The mass difference of 71.03601 between 12 and
13 suggested an additional alanine residue from the N-terminus. Similarly, the MS2 spectra at m/z
1985.77539 and 993.39203 were recorded and submitted to GNPS and processed by RiPPquest, and led
to the identification of the candidate peptide (ACSSTCTSGPFTFACDGTTKG), including an additional
alanine which might due to the alternative cleavage of RumM.
Marfey’s reaction [74]: Compounds 12 and 13 (0.1 mg each) were hydrolyzed separately by
6 N HCl (1.0 mL) at 110 ◦C for 15 h. Then HCl was removed using a SpeedVac and 20 µL FDAA
(1-fluoro-2,4-dinitrophenyl-5-L-alanine amide, 10 mg/mL in acetone) and 100 µL NaHCO3 (1 N
aqueous solution) were added. The reaction was heated at 80 ◦C for 10 min, and the reaction quenched
by addition of 50 µL 2 N HCl. L- and D-phenylalanine and L- and D-alanine, glycine, L- and D-serine,
L- and D-theorine, and L- and D-proline were converted accordingly. After centrifugation for 10 min
at 13,000 rpm, the reaction mixture was analyzed by UHPLC-MS (Figures S29 and S30). Five µL of the
reaction mixture were injected and analyzed using the following gradient: 0–1 min, 10% B; 1–7 min,
10–100% B; 7.1–10 min, 100% B (A: dd H2O with 0.1% formic acid; B: MeCN with 0.1% formic acid) at
a flow rate of 0.7 mL/min.
Ser/Cys labeling: Actinomadura sp. RB29 was first incubated in 50 mL ISP2 at 30 ◦C (150 rpm
shaking) for one week. Then, biomass was collected by centrifugation (4000 rpm, 10 min, rt), washed
twice using autoclaved minimal media and transferred into 100 mL minimal media containing
L-serine-2,3,3-D3 (100 mg) and DL-cystein-3,3-D2 (100 mg), respectively. The cultures were incubated
for one week at 30 ◦C (150 rpm). The culture broth was collected by filtration and extracted with
activated HP20 resin (20 g/L) at 4 ◦C overnight. The resin was washed by H2O firstly then eluted
by 100% MeOH. The MeOH eluate was concentrated under reduced pressure and resuspended into
MeOH for LCMS analysis and ESI-HRMS analysis (Figure S24–27).
Gene cluster identification: The putative biosynthetic gene cluster of rubromidin (rum) was
predicted using antiSMASH and compared with already described lantipeptide gene cluster cin (from
Streptomyces cinnamoneus) and putative biosynthetic gene cluster of cinnamycin B from Actinomadura
atramentaria [39,40,75] (Figure S6, Table S11). The peptide sequence of lantibiotic cinnamycin precursor
(predicted with antiSMASH) was used for al BLASTp search in GenBank using “refseq protein” or
“nonredundant protein sequence” database. A phylogenetic analysis was performed using lantibiotic
cinnamycin precursor peptide sequence (GenBank accession number WP 103565569) and LanM
lanthipeptide synthetase (GenBank accession number WP 103565568) and related hits from the
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BLASTp search. Phylogentic trees are shown in Figures S3 and S4. Comparative sequence alignment
of precursor peptide sequence is shown in Figure S5. Sequences were aligned with Muscle [62].
Two different phylogenetic trees were reconstructed with neighbor-joining and maximum-likelihood
algorithms [63,64]. The evolutionary distance model of Jones, Taylor, and Thorton [76] was used to
generate evolutionary distance matrices for the maximum likelihood and neighbor joining algorithm
with deletion of complete gaps and missing data. For the maximum-likelihood algorithm, a discrete
Gamma distribution was used (+G). For the neighbor-joining algorithm, the rate variation among sites
was modeled with a gamma distribution. For all constructed trees the confidence values of nodes were
evaluated by bootstrap analysis based on 1000 resamplings.
5. Conclusions
This study provides an extended taxonomical and chemical analysis of Actinobacteria isolated
from the fungus-growing termite M. natalensis. Our findings clearly verify that a high diversity of
Actinobacteria can be found with these termites, and most notably the termite gut. The high recovery
rates from gut fluids suggest that most species survive the relatively short passage and are inoculated
together with the fungal mutualists into the fresh fungus comb. Although the high phylogenetic
diversity denotes a certain lack of specificity between bacteria and origin of isolation, it simultaneously
ensures the presence of diverse chemistry and biochemical capacity, which may be necessary for
protection against alien species and the assisted breakdown of complex plant material. It also needs to
be noted that antibiotics at higher concentrations might be deployed as weapons against competing
microbes; they also have been found to elicit changes in the global bacterial transcription patterns and
metabolism at sub-inhibitory concentrations [77,78]. Therefore, it could be speculated that natural
products, including antibiotics, serve as signaling molecules between different microorganisms within
the termite symbiosis and contribute to the overall unique stability of the system. Consequently,
the structural diversity of metabolites produced within the mutualistic agricultural system might
provide a net benefit for the fungal mutualist and farming termites; however, documenting the
individual compounds and costs and benefits involved in this potential mutualism are still required.
An intriguing feature of studying the defensive symbiosis paradigm is its parallel to human
medicine as it both deploys mediating or antagonistic molecules to suppress pathogens. Insect
defensive symbioses, such as the fungus-growing termite systems, probably offer the clearest window
into antibiotic use in nature, and the presence of natural product factories, such as Actinobacteria,
represent an untapped chemical treasure trove of novel chemical scaffolds, a fact that is underlined
by the impressive amount of new natural product scaffolds derived from termite-associated bacteria
reported in the last decade. However, key to the discovery of new natural products is the ability to
mimic the natural environment and the dynamics present within the system. As exemplified in our
two case studies, co-culture assays are a first step towards mimicking natural habitats and identifying
key secondary metabolites from both bacteria and fungi. However, more efforts are clearly needed to
steadily increase the levels of complexity and more holistically describe the metabolic network within
the symbiosis.
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RumM, Figure S5: Comparative sequence alignment of precursor peptide sequence, Figure S6: Comparative gene
maps of rum and cin and proposed cinnamycin B biosynthetic clusters, Figures S7–S30: NMR spectra and LCMS
of Marfey’s reaction.
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